p38 MAP Kinase Inhibitor III Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
(S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC
50 = 0.90 μM
in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC
50s = 0.37 and 0.044 μM, respectively).
Allgemeine Beschreibung
A cell-permeable methylsulfanylimidazole compound that acts as a potent, selective, reversible, and ATP-competitive p38 MAP kinase inhibitor (IC
50 = 0.38 μM for p38α). Shown to effectively suppresses LPS-induced cytokine release both
in vitro (IC
50 = 0.16 and 0.039 μM for TNF-α and IL-1β release, respectively, in human PBMC) and
in vivo (ED
50 = 1.33 mg/kg for TNF-α release in mouse). When compared with SB 203580 (Cat. No.
559389 and
559398), it exhibits reduced inhibitory activity against cytochrome P450-2D6 isoform and, therefore, is better suited for
in vivo use. A 10 mM (1 mg/247 μl) solution of p38 MAP Kinase Inhibitor III (Cat. No.
506148) in DMSO is also available.
Biochem/physiol Actions
Cell permeable: yes
p38 MAP Kinase Inhibitor III Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte